Author + information
- Received September 24, 2014
- Revision received April 14, 2015
- Accepted July 2, 2015
- Published online October 1, 2015.
- Giuseppe Alessandrino, MD,
- Bernard Chevalier, MD,
- Thierry Lefèvre, MD,
- Francesca Sanguineti, MD,
- Philippe Garot, MD,
- Thierry Unterseeh, MD,
- Thomas Hovasse, MD,
- Marie-Claude Morice, MD and
- Yves Louvard, MD∗ ()
- Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Générale de Santé, Massy, France
- ↵∗Reprint requests and correspondence:
Dr. Yves Louvard, Hopital Jacques Cartier, L’angio, 6 avenue du Noyer Lambert, 91300 Massy, France.
Objectives This study sought to develop a scoring model predicting percutaneous coronary intervention (PCI) success in chronic total occlusions.
Background Coronary chronic total occlusion is the lesion subtype in which angioplasty is most likely to fail. Chronic total occlusion for PCI (CTO-PCI) failure is associated with higher 1-year mortality and major adverse cardiac events compared with successful CTO-PCI. Although several independent predictors of final procedural success have been identified, no study has yet produced a model predicting final procedural outcome.
Methods Data from 1,657 consecutive patients who underwent a first-attempt CTO-PCI were prospectively collected. The scoring model was developed in a derivation cohort of 1,143 patients (70%) using a multivariable stepwise analysis to identify independent predictors of CTO-PCI failure. The model was then validated in the remaining 514 (30%).
Results The overall procedural success rate was 72.5%. Independent predictors of CTO-PCI failure were identified and included in the clinical and lesion-related score (CL-score) as follows: previous coronary artery bypass graft surgery +1.5 (odds ratio [OR]: 2.49, 95% confidence interval [CI]: 1.56 to 3.96), previous myocardial infarction +1 (OR: 1.6, 95% CI: 1.17 to 2.2), severe lesion calcification +2 (OR: 2.72, 95% CI :1.78 to 4.16), longer CTOs +1.5 (≥20 mm OR: 2.04, 95% CI: 1.54 to 2.7), non–left anterior descending coronary artery location +1 (OR: 1.56, 95% CI: 1.14 to 2.15), and blunt stump morphology +1 (OR: 1.39, 95% CI: 1.05 to 1.81). Score values of 0 to 1, >1 and <3, ≥3 and <5, and ≥5 identified subgroups at high, intermediate, low, and very low probability, respectively, of CTO-PCI success (derivation cohort: 84.9%, 74.9%, 58%, and 31.9%; p < 0,0001; validation cohort: 88.3%, 73.1%, 59.4%, and 46.2%; p < 0.0001).
Conclusions This clinical and angiographic score predicted the final CTO-PCI procedural outcome of our study population.
Dr. Chevalier is a consultant for Abbott Vascular, Medtronic, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received September 24, 2014.
- Revision received April 14, 2015.
- Accepted July 2, 2015.
- 2015 American College of Cardiology Foundation